Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
BCBS of Massachusetts and the Federal Employee Program (FEP) generally offer broader anti-obesity medication coverage, while other affiliates may limit coverage to non-GLP-1 options
Disclaimer This page is an educational research reference and is not medical advice
To date, few cutaneous allergic reactions have been reported with DPP-4 inhibitors, although a recent report of drug-induced bullous pemphigoid in patients treated with vildagliptin ( n = 4) and sitagliptin ( n = 1) requires further investigation [21]
The risk of hypoglycemia may be lowered by a reduction in the dose of sulfonylurea (or other concomitantly administered insulin secretagogues) or insulin
US$ 28.73
US$ 25.07
US$ 26.61
US$ 25.24
